CATALOGO DEI PRODOTTI DELLA RICERCA

GATTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.818
NA - Nord America 9.320
AS - Asia 4.298
SA - Sud America 92
AF - Africa 49
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 10
Totale 23.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.276
GB - Regno Unito 3.861
CN - Cina 2.638
SG - Singapore 1.265
IT - Italia 988
RU - Federazione Russa 868
SE - Svezia 838
DE - Germania 807
FR - Francia 781
IE - Irlanda 740
FI - Finlandia 533
UA - Ucraina 190
JP - Giappone 100
TR - Turchia 97
BR - Brasile 53
BE - Belgio 43
VN - Vietnam 41
CA - Canada 36
NL - Olanda 36
HK - Hong Kong 31
KR - Corea 28
TG - Togo 27
ID - Indonesia 20
RO - Romania 19
AT - Austria 18
IR - Iran 18
ES - Italia 16
CL - Cile 15
IN - India 13
CZ - Repubblica Ceca 11
PT - Portogallo 10
AR - Argentina 9
AU - Australia 9
CH - Svizzera 9
ZA - Sudafrica 9
A2 - ???statistics.table.value.countryCode.A2??? 7
EG - Egitto 7
IQ - Iraq 7
SK - Slovacchia (Repubblica Slovacca) 7
BG - Bulgaria 5
HR - Croazia 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
QA - Qatar 5
VE - Venezuela 5
AL - Albania 4
DK - Danimarca 4
MA - Marocco 4
MX - Messico 4
SA - Arabia Saudita 4
EC - Ecuador 3
EE - Estonia 3
HU - Ungheria 3
IL - Israele 3
LV - Lettonia 3
PE - Perù 3
AM - Armenia 2
BD - Bangladesh 2
EU - Europa 2
GR - Grecia 2
LK - Sri Lanka 2
LT - Lituania 2
MK - Macedonia 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MS - Montserrat 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 23.601
Salva come PNG Salva come JPEG
Città #
Southend 3.637
Chandler 1.642
Jacksonville 1.497
Singapore 1.007
Woodbridge 797
Dublin 732
Ann Arbor 645
Ashburn 516
Houston 463
Beijing 402
Wilmington 312
Princeton 305
Lawrence 304
Jinan 251
Nanjing 217
Shenyang 204
New York 195
Bologna 190
Redmond 190
Verona 175
Helsinki 146
Hebei 133
Sindelfingen 124
Tianjin 109
Changsha 91
Tokyo 89
Haikou 86
Milan 86
Ningbo 85
Zhengzhou 81
Nanchang 80
Taizhou 67
Boardman 66
Hangzhou 64
Jiaxing 64
Taiyuan 61
Guangzhou 54
Seattle 46
Redwood City 45
Norwalk 43
Washington 43
Brussels 42
San Francisco 41
Falls Church 40
Los Angeles 39
Santa Clara 39
Fairfield 37
Moscow 36
Fuzhou 34
Lanzhou 34
Düsseldorf 31
Detroit 30
Lomé 27
Dallas 26
Dearborn 26
Lancaster 26
Seoul 21
Dong Ket 19
Dongguan 19
Orani 19
Jakarta 18
Toronto 18
Hong Kong 17
Nürnberg 17
Vienna 17
Rome 16
Sanayi 16
Chicago 14
Auburn Hills 13
Kent 13
Venice 13
Frankfurt am Main 12
Phoenix 12
Munich 11
Romola 11
London 10
Shanghai 10
Amsterdam 9
Boydton 8
Esslingen am Neckar 8
Florianópolis 8
Montréal 8
Trieste 8
Bârlad 7
Denver 7
Leawood 7
Miami 7
Novokuznetsk 7
Philadelphia 7
Turin 7
Brasília 6
Brno 6
Buenos Aires 6
Clearwater 6
Des Moines 6
Kemerovo 6
Padova 6
Paris 6
Seo-gu 6
Tübingen 6
Totale 16.326
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 249
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 178
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 150
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 146
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 145
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 140
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 137
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 133
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 131
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 123
[Therapeutic strategies in osteoporosis: whom and when to treat] 122
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 122
Rapporti tra sistema immune e metabolismo osseo 120
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 120
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 119
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 119
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 117
Bone metabolism in patients with anorexia nervosa and amenorrhoea 117
DXA bone mineral density in males: retrospective study in real life. 116
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 116
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 116
Prevalence and incidence of rheumatoid arthritis in Italy. 116
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 115
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 115
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 114
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 112
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 111
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 110
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 109
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 109
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 108
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 108
Osteoporosis treatment: why ibandronic acid? 107
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 107
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 106
Guidelines for the diagnosis, prevention and management of osteoporosis 106
Coxibs: a significant therapeutic opportunity. 105
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 105
Anti-CCP antibodies and bone 104
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 103
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 103
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 102
Prevalence of osteoporosis in patients affected by mastocytosis 102
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 102
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 102
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 102
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 101
Association between bone mineral density and serum lipid in men 101
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 101
Safety issues and adverse reactions with osteoporosis management 100
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 100
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 100
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 100
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 99
Could γ\δ T-cells explain zoledronic acid adverse events? 98
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 98
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 97
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 97
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 97
Bone involvement and osteoporosis in mastocytosis. 96
Bone turnover markers in patients with osteogenesis imperfecta 95
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 95
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 95
Periostin: The bone and beyond 95
Positive effects of cyclic administration of intravenous neridronate in growing patients with osteogenesis imperfecta 94
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 94
Association between bone mineral density and serum lipids in men 94
Bone turnover markers in patients with osteogenesis imperfecta. 94
[Antinflammatory therapy and cardiovascular risk: a consensus view]. 94
[Risk factors for hip fracture in elderly persons]. 92
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 92
Duration of treatment for osteoporosis 92
The radiological assessment of vertebral osteoporosis 91
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 91
Sclerostin and DKK1 in primary hyperparathyroidism. 91
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 91
Drug-induced osteonecrosis of the jaw: the state of the art 91
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 91
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 91
Peak bone mass and peak bone density. 91
Effects of denosumab on peripheral lymphocyte subpopulations 91
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 90
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 90
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 90
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 90
The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review 90
The radiological assessment of vertebral osteoporosis 88
Chronic intravenoous aminobisphosphonate therapy increase high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 88
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 88
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 88
Association between lipid profile and bone mass in healthy men 87
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 87
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 87
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 87
Intravenous bisphosphonate therapy increases radial width in adults with Osteogenesis Imperfecta. 86
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 86
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 86
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 86
The obesity paradox and osteoporosis 86
Variazione della densità minerale ossea ed attività antifratturativa; 86
Totale 10.515
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.435
article - articoli 86.842
book - libri 0
conference - conferenze 389
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.204
Totale 178.870
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.686 0 0 0 0 0 284 282 256 195 211 113 345
2020/20212.635 300 518 71 330 325 268 61 156 231 18 260 97
2021/20222.372 197 612 27 111 120 113 37 130 170 65 196 594
2022/20234.917 374 430 478 891 434 1.182 56 262 536 46 167 61
2023/20242.542 106 207 229 307 307 415 112 184 43 100 366 166
2024/20252.580 358 449 296 1.028 348 101 0 0 0 0 0 0
Totale 24.103